Back to Journals » OncoTargets and Therapy » Volume 12

Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report

Total article views   HTML views PDF downloads Totals
8,689 Dovepress* 6,310+ 1,126 7,436
PubMed Central* 2,379 405 2,784
Totals 8,689 1,531 10,220
*Since 18 December 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar